# Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients

> **NCT01298960** · PHASE2 · TERMINATED · sponsor: **Fundacion Dexeus** · enrollment: 52 (actual)

## Conditions studied

- Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer

## Interventions

- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT01298960
- **Lead sponsor:** Fundacion Dexeus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298960, "Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01298960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*